Scar formation reduction

Scar formation reduction is a therapeutic objective focused on modulating the body's natural response to tissue injury to prevent excessive fibrous tissue deposition (PubMed, PMC4221994). This physiological process is not a single molecular target but a coordinated biological response involving the inflammatory, proliferative, and remodeling phases of wound healing (StatPearls, NBK535404). Central to this process is the signaling of Transforming Growth Factor Beta (TGF-beta), which drives fibroblast differentiation into myofibroblasts and subsequent collagen overproduction (UniProt, P01137). Pathological outcomes of dysregulated healing include hypertrophic scars and keloids, which are characterized by high levels of Type I collagen and decreased matrix degradation (NIH, 2022). Therapeutic strategies often target specific proteins within this cascade, such as CTGF or Smad proteins, to shift the balance from fibrosis toward regenerative healing (PubMed, PMC2874136).

Other names

AntiscarringScar preventionInhibition of cicatrizationModulation of wound healingFibrosis reduction

Modulation of the wound healing cascade through the inhibition of fibroblast proliferation, suppression of pro-fibrotic cytokines like TGF-beta, downregulation of collagen synthesis, and induction of myofibroblast apoptosis (PubMed, PMC4221994; StatPearls, NBK535404).